Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution
Joshua Kellner(The University of Texas MD Anderson Cancer Center), Simrit Parmar(The University of Texas MD Anderson Cancer Center)
Cited by 45
Related Papers
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma
|Blood|2021|213
CRP and ferritin in addition to the EASIX score predict CAR-T–related toxicity
|Blood Advances|2021|146
Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma
|Blood Advances|2020|114
Role of the p38 Mitogen-activated Protein Kinase Pathway in the Generation of the Effects of Imatinib Mesylate (STI571) in BCR-ABL-expressing Cells
|Journal of Biological Chemistry|2004|71
Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus
|Frontiers in Immunology|2023|14